Invo Bioscience Inc Expected To Post A Loss Of 19 Cents A Share: Earnings Preview

INVO Fertility

13/08/2021 21:24

* INVO Bioscience Inc  INVO.OQ   INVO.O  is expected to report
results on August 16.
* The Lakewood Ranch, Florida-based company is expected to
report revenue of $409.5 thousand, according to the mean
estimate from 2 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for INVO Bioscience Inc is
for a loss of 19 cents per share. 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for INVO Bioscience
Inc is $5.88​, about 28.5% above​ its last closing price
of $4.20. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.18       -0.17      -0.25     Missed  -42.9
 Dec. 31 2020  -0.21       -0.21      -0.60     Missed  -179.1
                                                        ​
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 13 at 20:24 GMT.  All
figures in US dollars unless otherwise stated